Because this chemical substrate is not specific to FXa activity, we also measured the ability of EVs from glioblastoma cells to induce coagulation in the clotting time, which is commonly used for the clinical evaluation of a systemic prothrombotic state in patients with cancer [34,35]. This evidence concerns the gene F10 and cancer.